Pharmaceuticals, Biotechnology & Life Sciences

Explore Teyi Pharmaceutical’s latest stock move – flat 0% with a price of CNY 8.87, 52‑week high 15.21, and 200‑day SMA 9.14, plus market cap details.

Beone Medicines (BeiGene) up 6.13%—market cap HKD 337.8 bn, 52‑week high HKD 236, 200‑day SMA HKD 194.5; invest insight on stock performance & peers.

Explore Zhejiang Tianyu Pharmaceut’s 2026 stock snapshot: price, market cap, trading trends, and industry context for investors.

Schott Pharma AG, a leading drug delivery solutions provider, trades at €25.5 with a €3.9 bn market cap—discover its latest market performance and insights.

Dogwood Therapeutics (DWTX) stocks are flat at $1.11, trading 21.7% lower from last month, with a 52‑week high of $7.04 and 200‑day SMA $2.02.

Biomarin Pharmaceutical stock dips 1.2%—trading around $55.75 with a $10.8 bn cap; see latest 52‑week highs, lows, and competitor moves.

Pharmaron Beijing -H stock: flat trade, CNY 38.1 price, 12.6% decline, 200‑day SMA at CNY 36.96, 52‑week high CNY 53.57 – key data for investors.

Mayne Pharma (MYX.AX) sees a 1.61% drop, trading around AUD 2.48 after a 16.95% monthly decline; latest 52‑week high at AUD 6.25 – insights on pricing, market cap and peer performance.

Celldex Therapeutics (CLDX) shares are priced at $29.50, trading down 7% month‑to‑date. Discover its biopharma focus, market cap, and recent price action.

Explore Sartorius Stedim Biotech’s latest market moves—EUR 216.8 per share, a 20.5 bn cap, and a 200‑day SMA at EUR 182.19—plus a quick look at peer performance.